Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open Label Clinical Trial to Evaluate the Safety and Efficacy of the COOLSTAT® Transnasal Thermal Regulating Device in Inducing Normothermia for Neurogenic Fever in an Intensive Care Setting

NCT06038513 is registered in ClinicalTrials.gov with CoolTech LLC as lead sponsor.

NCT NCT06038513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06038513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open Label Clinical Trial to Evaluate the Safety and Efficacy of the COOLSTAT® Transnasal Thermal Regulating Device in Inducing Normothermia for Neurogenic Fever in an Intensive Care Setting
Lead sponsor
CoolTech LLC
Phase
Not applicable
Overall status
Terminated
Start date
November 21, 2023
Completion date
November 30, 2025
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic encephalopathy, seizures, stroke hemorrhagic, stroke, ischemic